Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Hiddo J.L. Heerspink, Rey Isidto, Frederik Persson et al.|Nephrology Dialysis Transplantation|2019

Cited by 216